Communications of the ACM
ACM Careers
Deepmind's Superpowerful AI Sets Its Sights on Drug Discovery
Demis Hassabis.
Credit: Simon Dawson/Bloomberg
DeepMind, the London-based artificial intelligence company owned by Alphabet Inc., is planning to let its software learn how to fold proteins, an important problem for drug discovery.
From Bloomberg
View Full Article
No entries found